Investment
Features
FeesSafety
Academy
More
Pluang+

CVS Caremark settles with FTC to enhance drug affordability and transparency for consumers.

Market News
14 Jul 2026
PRNewsWire
View Source
Bullish
pluang ai news

CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS to focus on lowering prescription drug costs and increasing transparency. CVS will implement measures such as aligning member cost sharing with net medication costs, simplifying pricing, expanding reporting transparency, capping insulin costs at $25/month, and promoting point-of-sale rebates. These steps build on CVS's existing efforts to reduce out-of-pocket expenses and improve drug pricing clarity for millions of Americans.

More News (CVS)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App